Golden State Wealth Management, LLC Summit Therapeutics Inc. Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 751 shares of SMMT stock, worth $15,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
751Holding current value
$15,725% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
207Shares Held
76.4MCall Options Held
2.01MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY24.4MShares$511 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$229 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$114 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$72.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.21B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...